United Services Automobile Association Has $821,000 Holdings in ICU Medical, Incorporated (NASDAQ:ICUI)

Share on StockTwits

United Services Automobile Association reduced its holdings in ICU Medical, Incorporated (NASDAQ:ICUI) by 13.6% during the 2nd quarter, Holdings Channel reports. The fund owned 3,261 shares of the medical instruments supplier’s stock after selling 515 shares during the quarter. United Services Automobile Association’s holdings in ICU Medical were worth $821,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in ICUI. First Trust Advisors LP boosted its holdings in shares of ICU Medical by 0.7% in the 1st quarter. First Trust Advisors LP now owns 90,395 shares of the medical instruments supplier’s stock worth $21,634,000 after acquiring an additional 600 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in shares of ICU Medical by 11.3% in the 1st quarter. Envestnet Asset Management Inc. now owns 21,258 shares of the medical instruments supplier’s stock worth $5,088,000 after acquiring an additional 2,164 shares in the last quarter. Swiss National Bank raised its position in ICU Medical by 3.1% in the 1st quarter. Swiss National Bank now owns 29,819 shares of the medical instruments supplier’s stock worth $7,137,000 after purchasing an additional 900 shares during the last quarter. Federated Investors Inc. PA raised its position in ICU Medical by 281.2% in the 1st quarter. Federated Investors Inc. PA now owns 24,765 shares of the medical instruments supplier’s stock worth $5,928,000 after purchasing an additional 18,269 shares during the last quarter. Finally, Citigroup Inc. raised its position in ICU Medical by 42.0% in the 1st quarter. Citigroup Inc. now owns 8,240 shares of the medical instruments supplier’s stock worth $1,972,000 after purchasing an additional 2,439 shares during the last quarter. 93.48% of the stock is currently owned by institutional investors and hedge funds.

Several research analysts recently weighed in on ICUI shares. Zacks Investment Research cut shares of ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, August 14th. ValuEngine upgraded shares of ICU Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Raymond James set a $185.00 price objective on shares of ICU Medical and gave the stock a “buy” rating in a research report on Friday, September 6th. BidaskClub cut shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, August 14th. Finally, TheStreet cut shares of ICU Medical from a “b-” rating to a “c+” rating in a research report on Monday, August 12th. One research analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $233.00.

In other ICU Medical news, Director Robert S. Swinney sold 239 shares of the company’s stock in a transaction on Monday, July 15th. The shares were sold at an average price of $248.73, for a total transaction of $59,446.47. Following the completion of the sale, the director now owns 19,662 shares in the company, valued at approximately $4,890,529.26. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert S. Swinney sold 2,078 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $165.18, for a total transaction of $343,244.04. Following the sale, the director now owns 17,345 shares of the company’s stock, valued at approximately $2,865,047.10. The disclosure for this sale can be found here. Insiders have sold a total of 5,317 shares of company stock valued at $864,931 in the last quarter. Corporate insiders own 11.40% of the company’s stock.

ICUI stock opened at $153.39 on Friday. The company has a 50 day moving average price of $159.03 and a 200 day moving average price of $212.69. ICU Medical, Incorporated has a fifty-two week low of $151.01 and a fifty-two week high of $284.69. The stock has a market capitalization of $3.18 billion, a PE ratio of 20.65 and a beta of 0.93.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Wednesday, August 7th. The medical instruments supplier reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.13. ICU Medical had a net margin of 3.56% and a return on equity of 12.41%. The firm had revenue of $312.30 million during the quarter, compared to analysts’ expectations of $315.47 million. During the same quarter in the previous year, the company posted $2.69 EPS. ICU Medical’s revenue was down 13.4% on a year-over-year basis. On average, equities research analysts anticipate that ICU Medical, Incorporated will post 7.21 earnings per share for the current year.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: Death Cross

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Set Canadian National Railway  PT at C$125.91
Analysts Set Canadian National Railway PT at C$125.91
Nuveen Asset Management LLC Makes New $12.13 Million Investment in Amphastar Pharmaceuticals Inc
Nuveen Asset Management LLC Makes New $12.13 Million Investment in Amphastar Pharmaceuticals Inc
218,359 Shares in TreeHouse Foods Inc.  Purchased by Nuveen Asset Management LLC
218,359 Shares in TreeHouse Foods Inc. Purchased by Nuveen Asset Management LLC
Nuveen Asset Management LLC Buys 212,253 Shares of Casella Waste Systems Inc.
Nuveen Asset Management LLC Buys 212,253 Shares of Casella Waste Systems Inc.
Nuveen Asset Management LLC Makes New $11.64 Million Investment in Old National Bancorp
Nuveen Asset Management LLC Makes New $11.64 Million Investment in Old National Bancorp
Nuveen Asset Management LLC Sells 247,514 Shares of NuShares ESG US Aggregate Bond ETF
Nuveen Asset Management LLC Sells 247,514 Shares of NuShares ESG US Aggregate Bond ETF


© 2006-2019 Ticker Report